Summarized by Masters of Longevity from Longevity Technology.
Five-year CLARITY-AD extension data report sustained clinical benefit for lecanemab.

Key Takeaways
- Lecanemab showed continued clinical benefits over five years.
- Five-year data suggest treatment effects were maintained long term.
- Findings are from a long-term extension and are observational.



